A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting
Abstract Background People with substance use disorder are at risk of complications of drug use and frequent hospitalization and may continue to use substances during admission to acute care. Acute care harm reduction strategies including oral or injectable prescription opioids may aid in care reten...
Main Authors: | Casey Wigg, Amy Nolen, Lisa Jauhal, Malika Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12954-023-00813-x |
Similar Items
-
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study
by: Michael Curtis, et al.
Published: (2023-03-01) -
First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada
by: Zachary Bouck, et al.
Published: (2023-06-01) -
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
by: Kaitlyn Jaffe, et al.
Published: (2023-04-01) -
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study
by: Dobischok S, et al.
Published: (2022-12-01) -
Evaluating the Impact of Increased Dispensing of Opioid Agonist Therapy Take-Home Doses on Treatment Retention and Opioid-Related Harm among Opioid Agonist Therapy Recipients: A Simulation Study
by: Narjes Shojaati, et al.
Published: (2023-08-01)